S218: A PHASE I/II STUDY OF GOLIDOCITINIB, A SELECTIVE JAK1 INHIBITOR, IN REFRACTORY OR RELAPSED PERIPHERAL T CELL LYMPHOMA

Bibliographic Details
Main Authors:	W.-S. Kim, D.-H. Yoon, Y. Song, H. Yang, J. Cao, D. Ji, Y. Koh, H. Jing, H.-S. Eom, J.-Y. Kwak, W.-S. Lee, J.-S. Lee, H.-J. Shin, J. Jin, M. Wang, J. Li, X. Huang, X. Deng, Z. Yang, J. Zhu
Format:	Article
Language:	English
Published:	Wiley 2022-06-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/01.HS9.0000843764.15785.8c

Internet